These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38277623)

  • 1. Malignancies and Lymphoproliferations in Children With Primary Immune Deficiency-A Single-center Experience.
    Aydogmus C; Turkyilmaz Ucar O; Kaplan Sarikavak S; Cipe F; Ulas S; Turan I; Naiboglu S; Yildirim I; Kalay G; Kapci N; Al S; Gokmirza Ozdemir P; Celiksoy MH
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e169-e173. PubMed ID: 38277623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases.
    Ballow M; Sánchez-Ramón S; Walter JE
    Front Immunol; 2022; 13():928062. PubMed ID: 35924244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
    Bienemann K; Borkhardt A; Klapper W; Oschlies I
    Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
    Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
    Front Immunol; 2018; 9():2400. PubMed ID: 30386345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary immunodeficiencies and lymphoma: a systematic review of literature.
    Herber M; Mertz P; Dieudonné Y; Guffroy B; Jung S; Gies V; Korganow AS; Guffroy A
    Leuk Lymphoma; 2020 Feb; 61(2):274-284. PubMed ID: 31580160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of immunodeficiency to lymphoid malignancy.
    Kersey JH; Shapiro RS; Filipovich AH
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S10-2. PubMed ID: 2840629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
    Latour S; Winter S
    Front Immunol; 2018; 9():1103. PubMed ID: 29942301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EBV-associated lymphoproliferative disorders].
    Overkamp M; Quintanilla-Martinez L; Fend F
    Pathologie (Heidelb); 2022 Jul; 43(4):282-291. PubMed ID: 35925225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
    Tatfi M; Hermine O; Suarez F
    Front Immunol; 2018; 9():3060. PubMed ID: 30662441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-associated smooth muscle tumors in ataxia-telangiectasia: a case report and review.
    Reyes C; Abuzaitoun O; De Jong A; Hanson C; Langston C
    Hum Pathol; 2002 Jan; 33(1):133-6. PubMed ID: 11823985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders.
    Shabani M; Nichols KE; Rezaei N
    Crit Rev Oncol Hematol; 2016 Dec; 108():109-127. PubMed ID: 27931829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal system involvement in patients with primary immunodeficiency: a single center experience.
    Guler T; Kulhas Celik I; Ergani AC; Gumus M; Emiroglu HH; Artac H
    Scand J Gastroenterol; 2024 Sep; 59(9):1130-1136. PubMed ID: 39007903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-barr virus-associated extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma) arising in the parotid gland of a child with ataxia telangiectasia.
    Bennett JA; Bayerl MG
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):e114-7. PubMed ID: 25692616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of malignancies in Turkish primary immunodeficiency patients; a multicenter study.
    Cekic S; Metin A; Aytekin C; Edeer Karaca N; Baris S; Karali Y; Kiykim A; Karakoc Aydıner E; Ozen A; Aslan T; Sevinir B; Aksu G; Kutukculer N; Kilic SS
    Pediatr Allergy Immunol; 2020 Jul; 31(5):528-536. PubMed ID: 32060950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.
    Boztug H; Hirschmugl T; Holter W; Lakatos K; Kager L; Trapin D; Pickl W; Förster-Waldl E; Boztug K
    J Clin Immunol; 2016 Aug; 36(6):533-40. PubMed ID: 27338827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.
    Somekh I; Marquardt B; Liu Y; Rohlfs M; Hollizeck S; Karakukcu M; Unal E; Yilmaz E; Patiroglu T; Cansever M; Frizinsky S; Vishnvenska-Dai V; Rechavi E; Stauber T; Simon AJ; Lev A; Klein C; Kotlarz D; Somech R
    J Clin Immunol; 2018 Aug; 38(6):699-710. PubMed ID: 30030704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency Disorders.
    McLaughlin LP; Bollard CM; Keller MD
    Front Immunol; 2018; 9():556. PubMed ID: 29616044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge.
    Costagliola G; Consolini R
    Clin Exp Immunol; 2021 Sep; 205(3):288-305. PubMed ID: 34008169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases.
    Parvaneh N; Filipovich AH; Borkhardt A
    Br J Haematol; 2013 Sep; 162(5):573-86. PubMed ID: 23758097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary immunodeficiencies and haemato-oncology].
    Müller J; Kovács G
    Orv Hetil; 2018 Dec; 159(49):2073-2078. PubMed ID: 30525881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.